Cargando…
Effects of Hyperuricemia on Renal Function of Renal Transplant Recipients: A Systematic Review and Meta-Analysis of Cohort Studies
BACKGROUND: Hyperuricemia is an independent risk factor of nephropathy, but its role in renal transplant recipients (RTRs) is controversial. METHODS: Based on the methods of Cochrane systematic reviews, we searched MEDLINE (1948–2011.6), EMBASE (1956–2011.6), CBM (Chinese Biomedicine Database) (1978...
Autores principales: | Huang, Yan, Li, Yu-Lin, Huang, He, Wang, Ling, Yuan, Wen-Ming, Li, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382160/ https://www.ncbi.nlm.nih.gov/pubmed/22745759 http://dx.doi.org/10.1371/journal.pone.0039457 |
Ejemplares similares
-
Switching from allopurinol to febuxostat: efficacy and safety in the treatment of hyperuricemia in renal transplant recipients
por: Li, Yanchun, et al.
Publicado: (2019) -
Efficacy and safety of febuxostat for treating hyperuricemia in patients with chronic kidney disease and in renal transplant recipients: A systematic review and meta-analysis
por: Liu, Xuzhong, et al.
Publicado: (2018) -
Comparison of efficacy and safety between febuxostat and allopurinol in early post‐renal transplant recipients with new onset of hyperuricemia
por: Shen, Xiaoju, et al.
Publicado: (2018) -
Risk factors and management of hyperuricemia after renal transplantation
por: Zi, Xiaoyu, et al.
Publicado: (2023) -
Cancer risks in recipients of renal transplants: a meta-analysis of cohort studies
por: Wang, Yu, et al.
Publicado: (2017)